WASHINGTON UNIVERSITY SCHOOL OF MEDICINE DEPARTMENT OF MEDICINE

• Questions or comments
• Search

My clinical interests are in the areas of early phase oncology drug development and cancers of the gastrointestinal (GI) tract. I am a member of the Developmental Therapeutics program for the Siteman Cancer Center where we aim to assist in the development of novel anticancer therapies by conducting Phase I clinical trials. I have an interest in incorporating genomics into these studies to eventually personalize cancer treatment. As a member of the GI oncology clinical team, I have a particular interest in cancers of the upper GI tract. In this regard, I design and conduct clinical trials for patients with esophageal, gastroesophageal junction and gastric cancers. With an aim towards personalized cancer care, we try to incorporate genomics or other correlative studies into these clinical trials.

Education

1989	BA, Rice University, Houston, TX
1993	MD, University of Texas Southwestern Medical School, Dallas, TX
2001	MHS, Duke University, Durham, NC

Post-graduate Training

1993-1994	Intern, Barnes Hospital at Washington University, St. Louis, MO
1994-1997	Internal Medicine Resident, Barnes Hospital at Washington University, St. Louis, MO
1997-2001	Hematology/Oncology Fellow, Duke University Medical Center, Durham, NC
1999-2001	Fellow in Clinical Pharmacology, GlaxoSmithKline

Academic Appointments

2001-2008	Assistant Professor of Medicine, Vanderbilt University Medical Center, Nashville, TN
2008-present	Associate Professor of Medicine, Washington University School of Medicine, St. Louis, MO

Board Certification

1996	Internal Medicine (ABIM)
2000	Medical Oncology (ABIM)

Honors & Awards

1999	American Association for Cancer Research Minority Scholar in Cancer Research
2000	American Association for Cancer Research Minority Scholar in Cancer Research
2000	Excellence in Teaching Award, Duke University Physician Assistants Program
2003-2004	Vanderbilt Physician-Scientist Development Award, Vanderbilt University

Professional Organizations

	American Association for Cancer Research
	American Society of Clinical Oncology
	Eastern Cooperative Oncology Group
	American College of Surgeons Oncology Group

Academic Committees

2002-2008	Institutional Review Board, Vanderbilt University Medical Center
2004-2006	Admissions Committee, Vanderbilt University School of Medicine
2005	ASCO Scientific Committee, Experimental Therapeutics: Molecularly Targeted Agents
2007	ACOSOG Medical Oncology Committee, Core Group Member
2008	ASCO Scientific Committee, Non-colorectal GI

Updated: July 15, 2008